The trial, funded by Novo Nordisk, the manufacturer of Wegovy (semaglutide), found the drug improved liver inflammation, scarring (fibrosis), and sometimes both in people with metabolic dysfunction-associated steatohepatitis (MASH)
How It Works The active ingredient, semaglutide, mimics the bodys natural GLP-1 hormone to help regulate blood sugar
Additional Research Areas Phase 3 TRIUMPH trials evaluate osteoarthritis, cardiovascular risk, kidney disease, and MASH
Semaglutide, a groundbreaking medication, may be the answer youve been searching for
You may have started a GLP-1 medication and noticed that you feel full much sooner than usual
With shortages of the branded drugs declared over, and the window for compounding copies closed, though, some virtual care companies are emerging as unlikely allies